about
Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunitiesImpact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma.Sex dependence of airflow limitation and air trapping in children with severe asthma.Progressive airflow limitation is a feature of children with severe asthma.Severe Asthma in Children: Insights from the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.The molecular phenotype of severe asthma in children.Breath formate is a marker of airway S-nitrosothiol depletion in severe asthmaBuffering airway acid decreases exhaled nitric oxide in asthma.Diesel exhaust particles induce cysteine oxidation and s-glutathionylation in house dust mite induced murine asthmaLL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adultsEarly characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit.Residential proximity to a major roadway is associated with features of asthma control in children.Nicotine stimulates nerve growth factor in lung fibroblasts through an NFκB-dependent mechanism.Airway and plasma leptin and adiponectin in lean and obese asthmatics and controlsThiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2.Characterization of a high TNF-α phenotype in children with moderate-to-severe asthmaAirway TGF-β1 and oxidant stress in children with severe asthma: association with airflow limitationDecreased expression of acetaminophen-metabolizing enzymes and glutathione in asthmatic children after acetaminophen exposure.Severe asthma in childhood: recent advances in phenotyping and pathogenesis.Cysteine oxidation impairs systemic glucocorticoid responsiveness in children with difficult-to-treat asthmaSevere asthma in children.Vitamin D and asthma.Severe Asthma in Children: Lessons Learned and Future Directions.Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthmaRisk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youthChildren with severe asthma have unique oxidative stress-associated metabolomic profiles.Severe asthma in school-age children: evaluation and phenotypic advances.Biomarkers of asthma and allergic airway diseases.Predictors of emergency department use in children with persistent asthma in metropolitan Atlanta, Georgia.Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?The effect of geographic access on severe health outcomes for pediatric asthma.Uncovering Longitudinal Health Care Behaviors for Millions of Medicaid Enrollees: A Multistate Comparison of Pediatric Asthma Utilization.Anxiety Contributes to Poorer Asthma Outcomes in Inner-City Black Adolescents.Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids.Out of One, Many: Moving beyond a Single Guideline toward Personalized Asthma Care for Obese Children.TGF-β1 Suppresses the Type I IFN Response and Induces Mitochondrial Dysfunction in Alveolar Macrophages.Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features.High-resolution metabolomics to identify urine biomarkers in corticosteroid-resistant asthmatic children.Inflammatory and Comorbid Features of Children Admitted to a PICU for Status Asthmaticus
P50
Q27694579-7B528020-8E97-4E7E-B467-F2B59885F107Q30276625-51003BF5-59CD-4AB3-97DE-1A287E43171BQ30371124-3DA3B1D7-6375-4C8F-AD78-E62691E95103Q30427622-398BF62E-EDF4-4606-9640-01C0242A30B1Q30429093-3190ABE1-B3C7-456B-907B-FE551088D7E4Q30431432-FB94A4F0-BB23-420E-94F9-A3321FE9898BQ30432832-20B7BF28-292C-4661-9899-EA8CF6BA65F8Q30435224-E2687F5D-550A-4E24-A58B-F4D3ED761A08Q30441823-5663DFF2-0FD6-4742-B0BA-966B802A18A9Q31114680-F35C0FE8-443A-479C-8941-C8393DF203F6Q33828335-31BFB94E-00ED-46D1-8662-9C1ABB115BC4Q33896619-8A0C35C5-B07E-4618-9F88-ACD6BEBAFB0FQ34277666-BECF37EF-336E-4976-B7BC-2192B6865FCAQ34309275-7F405FD2-B70D-4A1F-A88F-DF533027812DQ34893354-BAD59995-DFF2-4D1B-88C9-7D075EBEA8DFQ35017206-FCA312F9-77A7-4A5B-8F31-AFA7178D1067Q35706650-A8DB4957-0F9B-401C-AF5C-B0F61724E373Q35713729-01561F86-1ED8-4F14-8D7B-6A6AFF7DBD69Q35803210-A4F604C3-0830-4000-82B3-7CAB76E602EEQ35848235-DDE1A85C-D922-4EF1-A54F-4B4B5FFF19C1Q35931658-8805BC68-1A7F-4428-933B-360C00389ADDQ36108246-66237F18-FEE7-4E10-9A65-15A3A8A8ED12Q36187597-C9C1D9AF-09F8-4D13-A4AE-6EC68B55D30DQ36471091-749AB2D7-9383-421D-B0D2-0659B2659EA6Q36741283-927DBC4D-FCA0-4838-9E81-84E105EF1352Q37029416-8C5E90CD-335F-49AA-BFE4-FDCADC83ABC3Q37561520-1F37AB01-A730-426F-871C-AD908FC3041DQ38541805-796D760E-3A2F-45A7-B609-721965129183Q38617249-7B954C26-E3C8-42C2-982F-886F19FD30CEQ38686851-E3E70D9B-4ECF-4EF3-87BD-218EF2AB7071Q39423956-2D022446-C608-4564-88D4-CC67CE7E6A0CQ41186988-EE447E58-A887-49E0-BFA8-1E6C6A322EB5Q47446638-7ED3B4B2-E73E-4A7F-A4AC-48027497EA4CQ47648614-CA7FE908-86C9-4B93-A663-C3F8DC41E5A7Q47671548-2A9491D1-1997-4A53-B34A-54B0EF73592CQ49494654-1B3C16C8-286C-4F6B-B77B-2B046EA1534EQ50088156-E2BB953A-9E1A-4F8E-84EC-ECE773355193Q51450884-19CF3A39-B25A-45C3-A3E7-C504707D2923Q53135691-8F8632BE-6434-4FBB-BBEB-731720BF3485Q57169733-3A800717-0CD1-4B94-80A2-4747A8235696
P50
description
researcher ORCID ID=0000-0002-2933-5926
@en
name
Anne Fitzpatrick
@en
Anne Fitzpatrick
@nl
type
label
Anne Fitzpatrick
@en
Anne Fitzpatrick
@nl
prefLabel
Anne Fitzpatrick
@en
Anne Fitzpatrick
@nl
P106
P108
P31
P496
0000-0002-2933-5926